In conclusion, ADSCs-EXO-ICA can adjust the M1-to-M2 phenotypic switch to alleviate RA by inhibiting glycolysis through blocking the ERK/HIF-1α/GLUT1 pathway. Here, HIF1A is linked to rheumatoid arthritis.